T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$3.46B |
| 2 |
UnitedHealth
UNH
|
+$2.79B |
| 3 |
Salesforce
CRM
|
+$2.38B |
| 4 |
Sherwin-Williams
SHW
|
+$1.41B |
| 5 |
Philip Morris
PM
|
+$1.34B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$4.44B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.97B |
| 3 |
GE Aerospace
GE
|
+$2.3B |
| 4 |
HCA Healthcare
HCA
|
+$2.17B |
| 5 |
American International
AIG
|
+$1.68B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.68% |
| 2 | Healthcare | 19.49% |
| 3 | Consumer Discretionary | 13.07% |
| 4 | Financials | 11.17% |
| 5 | Communication Services | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2076
Arbor Realty Trust
ABR
$981M
| $666K | ﹤0.01% |
50,805
+1,904
| +4% | +$30.6K |
|
2077
Peapack-Gladstone Financial
PGC
$822M
| $665K | ﹤0.01% |
22,381
+2,748
| +14% | +$88K |
|
2078
BancFirst
BANF
$3.89B
| $662K | ﹤0.01% |
6,916
+358
| +5% | +$31.2K |
|
2079
National Presto Industries
NPK
$987M
| $662K | ﹤0.01% |
10,089
+1,746
| +21% | +$124K |
|
2080
Modine Manufacturing
MOD
$10.8B
| $660K | ﹤0.01% |
62,693
+366
| +0.6% | +$3.46K |
|
|
BIG
2081
DELISTED
Big Lots, Inc.
BIG
| $660K | ﹤0.01% |
31,472
+9,109
| +41% | +$268K |
|
|
MTOR
2082
DELISTED
MERITOR, Inc.
MTOR
| $660K | ﹤0.01% |
18,166
+565
| +3% | +$20.3K |
|
2083
AngioDynamics
ANGO
$647M
| $659K | ﹤0.01% |
34,061
+106
| +0.3% | +$2.17K |
|
|
TPIC
2084
DELISTED
TPI Composites
TPIC
| $659K | ﹤0.01% |
52,752
-9,500
| -15% | -$124K |
|
|
ASTR
2085
DELISTED
Astra Space, Inc. Class A Common Stock
ASTR
| $659K | ﹤0.01% |
33,809
+11,571
| +52% | +$472K |
|
2086
NewMarket
NEU
$8.72B
| $654K | ﹤0.01% |
2,173
-1
| -0% | -$323 |
|
2087
Benchmark Electronics
BHE
$2.89B
| $653K | ﹤0.01% |
28,957
+3,814
| +15% | +$92K |
|
|
ALEX
2088
DELISTED
Alexander & Baldwin
ALEX
| $652K | ﹤0.01% |
36,324
+477
| +1% | +$9.83K |
|
2089
Trupanion
TRUP
$1.36B
| $652K | ﹤0.01% |
10,828
+314
| +3% | +$21.4K |
|
2090
Travere Therapeutics
TVTX
$5.79B
| $651K | ﹤0.01% |
26,868
+10,382
| +63% | +$261K |
|
2091
Beyond Meat
BYND
$210M
| $649K | ﹤0.01% |
27,109
+5,696
| +27% | +$182K |
|
2092
Cohu
COHU
$2.76B
| $649K | ﹤0.01% |
23,381
-6,672
| -22% | -$184K |
|
2093
1st Source
SRCE
$2.13B
| $649K | ﹤0.01% |
14,306
-3,460
| -19% | -$156K |
|
|
IRBT
2094
DELISTED
iRobot
IRBT
| $646K | ﹤0.01% |
17,576
+335
| +2% | +$16.2K |
|
|
MRSN
2095
DELISTED
Mersana Therapeutics
MRSN
| $646K | ﹤0.01% |
5,593
+72
| +1% | +$6.77K |
|
2096
Impinj
PI
$5.46B
| $646K | ﹤0.01% |
11,016
+344
| +3% | +$17.3K |
|
2097
Theravance Biopharma
TBPH
$878M
| $646K | ﹤0.01% |
71,313
+25,905
| +57% | +$239K |
|
2098
Univest Financial
UVSP
$1.19B
| $645K | ﹤0.01% |
25,346
+252
| +1% | +$6.46K |
|
2099
Dillards
DDS
$9.59B
| $642K | ﹤0.01% |
2,910
+422
| +17% | +$122K |
|
2100
Fastly Inc
FSLY
$4.78B
| $642K | ﹤0.01% |
55,323
+5,877
| +12% | +$82.9K |
|
Similar funds
T. Rowe Price Associates's Q2 2022 Portfolio in Review
As of Q2 2022, T. Rowe Price Associates held 3,063 positions worth $791B, down 20% from $992B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2022 filing shows 88 new, 1,490 increased, 1,207 reduced and 101 closed positions. Its largest new stake was ESAB: 6,073,363 shares worth $266M. The largest sale was Meta Platforms (Facebook), an estimated $4.44B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2022 buy was ESAB: 6,073,363 shares worth $266M.
- T. Rowe Price Associates added most to Becton Dickinson in Q2 2022, an estimated $3.46B increase.
- T. Rowe Price Associates's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $4.44B.
- T. Rowe Price Associates fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $364M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $791B portfolio in Q2 2022.
- T. Rowe Price Associates opened 88 new positions and closed 101 in Q2 2022.
- T. Rowe Price Associates's portfolio value fell 20% quarter-over-quarter to $791B.
Based on T. Rowe Price Associates's 13F filing for Q2 2022, filed 15 Aug 2022.